Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

News Conference News EACTS 2021

Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First

Michael O'Riordan

October 19, 2021

ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year

News Conference News TCT 2018

ReCre8: Physician-Led Study Shows Noninferiority of Polymer-Free Stent Compared With Permanent-Polymer ZES at 1 Year

Yael L. Maxwell

September 22, 2018

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

November 02, 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

June 16, 2017

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

November 08, 2015

News Conference News AHA 2014

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

November 15, 2014

News Conference News TCT 2012

Watchman LAA Effective in Patients Contraindicated for Warfarin

October 26, 2012

News Conference News ESC 2012

PCI Fails to Match CABG in Diabetic Patients with Multivessel Disease

Yael L. Maxwell

August 27, 2012

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

April 08, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

April 05, 2011

Video

» On Record

Understanding Noninferiority Trials: Purpose, Power, and Pitfalls

September 24, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.